BioSpace News Archive

BioCapital

Medcura Receives Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat

Medcura, Inc., a medical device company dedicated to transformatively improving the management of surgical bleeding, announces that the U.S. Food and Drug Administration (FDA) has granted the coveted Breakthrough Device Designation for its LifeGel™ Absorbable Surgical Hemostat.

January 12, 2023
·
3 min read
BioMidwest

HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND’S INNOVESTOR LIFE SCIENCE FUND AND TESI

HVR Cardio, a clinical stage medical technology company developing Structural Heart cardiovascular products for transcatheter mitral valve repair, announced today that it has closed on its 10.7 million Euro ($11.1M US) Series B Round of financing.

January 12, 2023
·
2 min read
Business

Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor Asset

Nerviano Medical Sciences S.r.l. announced the senior appointment to drive validation and maximize the value of its IDH1/IDH2 Inhibitor Asset, NMS-173, and facilitate its expanding and advancing clinical pipeline.

January 12, 2023
·
5 min read
FDA

Novo Nordisk announces FDA approval of label update for Rybelsus® (semaglutide) allowing use as a first-line option for adults with type 2 diabetes

The U.S. Food and Drug Administration has approved a label update for Rybelsus® tablets 7 mg or 14 mg, allowing use as a first-line treatment option for adults with type 2 diabetes who have not previously taken a diabetes treatment.

January 12, 2023
·
8 min read